MEDICINE DETAILS
Tyruko
Active ingredient: Natalizumab Sztn
Neutral reference profile for an independent medicine-access consultancy enquiry about Tyruko (Natalizumab Sztn). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Tyruko used for?
Tyruko (natalizumab-sztn) is indicated for the treatment of:
Multiple Sclerosis (MS)
Tyruko (natalizumab-sztn) is prescribed as monotherapy for the treatment of adult patients with relapsing forms of MS, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Note: Tyruko (natalizumab-sztn) may increase the risk of progressive multifocal leukoencephalopathy (PML). This risk should be considered against the expected benefit of Tyruko (natalizumab-sztn) when starting or continuing treatment.
Crohn’s Disease (CD)
Tyruko (natalizumab-sztn) is indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn’s disease with evidence of inflammation. It’s intended for patients who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of TNF-α.
Note: In CD, Tyruko (natalizumab-sztn) should not be used together with immunosuppressants or inhibitors of TNF-α.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Tyruko identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
300 mg · 1 vial Catalogue organisation: Hexal AG
OFFICIAL SOURCES
Check the Tyruko record at an official source.
Search for “Tyruko” or “Natalizumab Sztn”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Tyruko.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Tyruko
01What is Tyruko?＋
This directory record associates the brand name Tyruko with the active ingredient Natalizumab Sztn. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Tyruko strengths and packs are recorded?＋
The catalogue currently shows: 300 mg · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Tyruko?＋
Catalogue records currently name: Hexal AG. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Tyruko?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Tyruko, payment request, stock guarantee or binding offer.
06Can I buy Tyruko from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.